Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 13, 1124 (2007)
doi:10.1038/nm1007-1124b
Karolinska Institute under fire for controversial cancer report
Cassandra Willyard1
- New York
It's no surprise that access to new cancer drugs varies from country to country. But can this discrepancy be to blame for poor survival rates in some countries?
To read this story in full you will need to login or make a payment (see right).
